The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.
Copyright 2021 NPR
Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine
Facebook Twitter LinkedIn Email